PHATPhathom Pharmaceuticals, Inc.
8.870USD-4.83%Mkt Cap: 717.59M $P/E: —3d ago
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III cli…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap717.59M $
Enterprise Value1.07B $
Revenue (TTM)239.66M $
Gross Profit152.51M $
Net Income (TTM)-221.25M $
Revenue/Share3.062 USD
Last Price8.870 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees371
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)7.75
PEG—
EV/EBITDA-26.54
EV/Revenue4.44
P/S2.90
P/B-2.00
EPS (TTM)-1.15
EPS (Forward)1.11
52W Range
8.2107% of range18.31
52W High18.31 USD
52W Low8.210 USD
Profitability
Gross Margin87.09%
Oper. Margin-5.34%
EBITDA Margin-16.75%
Profit Margin-126.35%
ROE50.49%
ROA-85.37%
Growth
Revenue Growth88.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-166.78M $
CapEx (TTM)229.00K $
FCF Margin-13.61%
FCF Yield-4.55%
Net Debt369.55M $
Net Debt/EBITDA-9.21
Balance Sheet
Debt/Equity-0.48
Current Ratio1.92
Quick Ratio1.82
Book Value/Sh-4.3000 USD
Cash/Share2.256 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.50 USD
Upside (mean)+142.4%
Target Range13.00 USD – 29.00 USD
$13.00+142.4% to mean$29.00
# Analysts10
Ownership
Shares Out.80.90M
Float65.29M
Insiders4.66%
Institutions92.16%
Short Interest
Short Ratio9.3d
Short % Float17.34%
Short % Out.16.47%
Shares Short13.33M
Short (prev mo.)11.99M
Technical
SMA 5010.37 (-14.5%)
SMA 20012.34 (-28.1%)
Beta0.50
S&P 52W Chg18.16%
Avg Vol (30d)1.55M
Avg Vol (10d)1.48M
Technical Indicators
RSI (14)40.4
MACD-0.4590
MACD Signal-0.5117
MACD Hist.+0.0528
BB Upper12.14 USD
BB Middle9.557 USD
BB Lower6.970 USD
BB Width54.14%
ATR (14)0.6221 USD
Vol Ratio (20d)0.55x